» Articles » PMID: 34361718

Polysaccharide Structures and Their Hypocholesterolemic Potential

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2021 Aug 7
PMID 34361718
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Several classes of polysaccharides have been described to have hypocholesterolemic potential, namely cholesterol bioaccessibility and bioavailability. This review will highlight the main mechanisms by which polysaccharides are known to affect cholesterol homeostasis at the intestine, namely the effect (i) of polysaccharide viscosity and its influence on cholesterol bioaccessibility; (ii) on bile salt sequestration and its dependence on the structural diversity of polysaccharides; (iii) of bio-transformations of polysaccharides and bile salts by the gut microbiota. Different quantitative structure-hypocholesterolemic activity relationships have been explored depending on the mechanism involved, and these were based on polysaccharide physicochemical properties, such as sugar composition and ramification degree, linkage type, size/molecular weight, and charge. The information gathered will support the rationalization of polysaccharides' effect on cholesterol homeostasis and highlight predictive rules towards the development of customized hypocholesterolemic functional food.

Citing Articles

The Cross-Talk Between the Peripheral and Brain Cholesterol Metabolisms.

Savulescu-Fiedler I, Dorobantu-Lungu L, Dragosloveanu S, Benea S, Dragosloveanu C, Caruntu A Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996836 PMC: 11853762. DOI: 10.3390/cimb47020115.


Ultrasonic/compound enzyme extraction, comparative characterisation and biological activity of Lonicera macranthoides polysaccharides.

Ren M, Hou Y, Peng D, Li H, Zhang X, Qiao L Ultrason Sonochem. 2025; 114:107259.

PMID: 39933310 PMC: 11867525. DOI: 10.1016/j.ultsonch.2025.107259.


An oat fiber intervention for reducing PFAS body burden: A pilot study in male C57Bl/6 J mice.

Schlezinger J, Biswas K, Garcia A, Heiger-Bernays W, Bello D Toxicol Appl Pharmacol. 2024; 495:117188.

PMID: 39647509 PMC: 11798698. DOI: 10.1016/j.taap.2024.117188.


Bioactive compound encapsulation: Characteristics, applications in food systems, and implications for human health.

Rezagholizade-Shirvan A, Soltani M, Shokri S, Radfar R, Arab M, Shamloo E Food Chem X. 2024; 24:101953.

PMID: 39582652 PMC: 11584689. DOI: 10.1016/j.fochx.2024.101953.


Melt-Processed Polybutylene-Succinate Biocomposites with Chitosan: Development and Characterization of Rheological, Thermal, Mechanical and Antimicrobial Properties.

Merijs-Meri R, Zicans J, Ivanova T, Mezule L, Ivanickins A, Bockovs I Polymers (Basel). 2024; 16(19).

PMID: 39408518 PMC: 11478647. DOI: 10.3390/polym16192808.


References
1.
Caffall K, Mohnen D . The structure, function, and biosynthesis of plant cell wall pectic polysaccharides. Carbohydr Res. 2009; 344(14):1879-900. DOI: 10.1016/j.carres.2009.05.021. View

2.
SALVIOLI G, Igimi H, Carey M . Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin and conjugated ursodeoxycholate-lecithin mixtures: dissimilar phase equilibria and dissolution mechanisms. J Lipid Res. 1983; 24(6):701-20. View

3.
Hernell O, Staggers J, Carey M . Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry. 1990; 29(8):2041-56. DOI: 10.1021/bi00460a012. View

4.
Jakobsdottir G, Xu J, Molin G, Ahrne S, Nyman M . High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLoS One. 2013; 8(11):e80476. PMC: 3827442. DOI: 10.1371/journal.pone.0080476. View

5.
Kusmiati , Dhewantara F . Cholesterol-Lowering Effect of Beta Glucan Extracted from Saccharomyces cerevisiae in Rats. Sci Pharm. 2016; 84(1):153-65. PMC: 4839553. DOI: 10.3797/scipharm.ISP.2015.07. View